Prostate cancer expression profiling by cDNA sequencing analysis

Genomics

Volumn 59, Issue 2, 1999, Pages 178-186

  Huang, Guyang Matthew ^a   Ng, Wai lap ^a   Farkas, James ^a   He, Lei ^a   Liang, Hongyu Annie ^a   Gordon, David ^a   Yu, Jun ^a   Hood, Leroy ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; TUMOR MARKER;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; DATA BASE; DNA SEQUENCE; DOT HYBRIDIZATION; EPITHELIUM CELL; EXPRESSED SEQUENCE TAG; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TUMOR GROWTH;

EID: 0033566225     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1999.5822     Document Type: Article

References (27)

1. Adams M. D., Kerlavage A. R., Fleischmann R. D., Fuldner R. A., Bult C. J., Lee N. H., Kirkness E. F., Weinstock K. G., Gocayne J. D., White O. Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotides of cDNA sequence. Nature. 377:1995;3-174.
2. Arya S. K. Comparison of the sequence complexity and abundance frequency of polyadenylated messenger RNA in human breast and prostate carcinoma cells. Cancer Res. 41:1981;3566-3570.
3. Burke J., Wang H., Hide W., Davison D. B. Alternative gene form discovery and candidate gene selection from gene indexing projects. Genome Res. 8:1998;276-290.
4. Djakiew D. Role of nerve growth factor-like protein in the paracrine regulation of prostate growth. J. Androl. 13:1992;476-487.
5. Dubnick M. Btab - A Blast output parser. Comput. Appl. Biosci. 8:1992;601-602.
6. Henikoff J. G., Henikoff S. Blocks database and its applications. Methods Enzymol. 266:1996;88-105.
7. Higgins D. G., Thompson J. D., Gibson T. J. Using CLUSTAL for multiple sequence alignments. Methods Enzymol. 266:1996;383-402.
8. Huang G., Farkas J., Hood L. High-throughput cDNA screening utilizing a low order neural network filter. BioTechniques. 21:1996;1110-1114.
9. Huang G., Wang K., Kuo C., Paeper B., Hood L. A high-throughput plasmid DNA preparation method. Anal. Biochem. 223:1994a;35-38.
10. Huang G. M., Gordon D., Farkas J., Hood L. Above and beyond database - A high-throughput system for cDNA sequence analysis. Venter J. C., Doyle D. Genome Sequencing and Analysis Conference VI. 1994b;Mary Ann Liebert, Inc. Hilton Head.
11. Huang X. On global sequence alignment. Comput. Appl. Biosci. 10:1994;227-235.
12. Isaacs W., Bova G., Morton R., Bussemakers M., Brooks J., Ewing C. Molecular biology of prostate cancer. Semin. Oncol. 21:1994;514-521.
13. Israeli R., Grob M., Fair W. Prostate-specific membrane antigen and other prostatic tumor markers on the horizon. Urol. Clin. North Am. 24:1997;439-450.
14. Kerlavage, A. R., Adams, M. D., Kelley, J. C., Dubnick, M., Powell, J., Shanmugam, P., Venter, J. C., and Fields, C.1993. Analysis and management of data from high-throughput expressed sequence tag projects. InProceedings of the Hawaiian International Conference on System Sciences, pp. 585-594, IEEE Computer Society, Hawaii.
15. Lennon G., Auffray C., Polymeropoulos M., Soares M. B. The I.M.A.G.E. Consortium: An integrated molecular analysis of genomes and their expression. Genomics. 33:1996;151-152.
16. Liu A., Corey E., Vessella R., Lange P., True L., Huang G., Nelson P., Hood L. Identification of differentially expressed prostate genes: Increased expression of transcription factor ETS-2 in prostate cancer. Prostate. 30:1997;145-153.
17. Matteis A. D. Tissue markers in the diagnosis and prognosis of prostatic carcinoma. Eur. Urol. 21:1992;66-70.
18. Nelson P., Ng W., True L., Liu A., Bumgarner R., Ferguson C., Dimak A., Hood L. An expressed-sequence-tag database of the human prostate: Sequence analysis of 1168 cDNA clones. Genomics. 47:1998;12-15.
19. Nixon R. G., Meyer G. E., Blase A. B., Gold M. H., Brawer M. K. Comparison of 3 investigational assays for the free form of prostate specific antigen. J. Urol. 160:1998;420-425.
20. Orr S., Gese E., Hood L. A new approach to understanding T cell development: The isolation and characterization of immature CD4-, CD8-, CD3-T cell cDNAs by subtraction cloning. Mol. Biol. Cell. 3:1992;761-773.
21. Orr S., Hughes T., Sawyers C., Kato R., Quan S., Williams S., Witte O., Hood L. Isolation of unknown genes from human bone marrow by differential screening and single-pass cDNA sequence determination. Proc. Natl. Acad. Sci. USA. 91:1994;11869-11873.
22. Ostrow R. S., Woods W. G., Vosika G. J., Faras A. J. Analysis of the genetic complexity and abundance classes of messenger RNA in human liver and leukemic cells. Biochim. Biophys. Acta. 562:1979;92-102.
23. Parsons J. D. Improved tools for DNA comparison and clustering. Comput. Appl. Biosci. 11:1995;603-613.
24. Pietrokovski S., Henikoff J. G., Henikoff S. The Blocks database - A system for protein classification. Nucleic Acids Res. 24:1996;197-200.
25. Reiter R., Gu Z., Watabe T., Thomas G., Szigeti K., Davis E., Wahl M., Nisitani S., Yamashiro J., Le Beau M., Loda M., Witte O. Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer. Proc. Natl. Acad. Sci. USA. 95:1998;1735-1740.
26. Seidman H., Mushinski M. H., Gelb S. K., Silverberg E. Probabilities of eventually developing or dying of cancer: United States. Chem. Abstr. 35:1985;36-56.
27. Thompson T. Growth factors and oncogenes in prostate cancer. Cancer Cells. 2:1990;345-354.